hCD45+ and hCD56+ cells were significantly increased in the MSLN.CAR-IL-15 iNK–treated MSLN+ tumor as compared to tumors from mice receiving mock iNK cells (Fig. 6, E and F). Here, IL15 is linked to neoplasm.